Answers are grounded in this paper and cite their sources.
Automated classification of brain tumors from MRI remains challenging due to the morphological and intensity variability across tumor subtypes. We propose NeuroNet-X, a hybrid deep learning architecture that integrates an ImageNet-pretrained ResNet-50 backbone, Convolutional Block Attention Modules (CBAM) inserted after Layer2–Layer4, a patch-embedding bridge, and a lightweight Vision Transformer (ViT) block. The framework was evaluated on three publicly available datasets: DS-1 (Bangladesh/Kaggle, 3-class), DS-2 (Figshare, 3-class), and DS-3 (Extended/Mendeley, 4-class). To address statistical reliability concerns raised in peer review, DS-2 and DS-3 results are reported as mean ± standard deviation across five independent random seeds with 95% confidence intervals. NeuroNet-X achieves 98.34± 0.59% accuracy (95% CI: 97.61–99.08%) on DS-2 and 96.66± 0.72% (95% CI: 95.77–97.55%) on DS-3. AUC values are 0.9995 ± 0.0001 and 0.9929 ± 0.0071 on DS-2 and DS-3 respectively. A data-leakage audit was performed prior to each experiment and duplicate training images were removed; the test sets were left intact to preserve comparability with prior work. Grad-CAM visualizations achieve a Pointing Game accuracy of 91.3% computed with manually annotated bounding boxes on DS-3 test images. These results indicate that NeuroNet-X is a technically sound decision-support framework for brain tumor categorization. However, the model was evaluated solely on retrospective 2D public benchmark datasets, and clinical deployment would require external multi-center validation, patient-level splitting, volumetric analysis, and clinician-in-the-loop reader studies.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: